Marcelo Cruz, VP of business Development and Marketing at Tjoapack, explores the secondary innovations poised to revolutionise the patient centricity of PFSs over the next decade.
Andrei Kuzmik Shutterstock
Optimising the future patient centricity of prefilled syringes
Marcelo Cruz, VP of business Development and Marketing at Tjoapack, explores the secondary innovations poised to revolutionise the patient centricity of PFSs over the next decade.
Published:
|
5 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.